5 hours ago • EIN Presswire
Inhalable Biologics Market Analysis 2025 – Insights for Long-Term Investment & Planning
5 hours ago • EIN Presswire
Inhalable Biologics Market Analysis 2025 – Insights for Long-Term Investment & Planning6 hours ago • kedglobal.com
S.Korea’s CDMO giant Samsung Biologics to offer CRO services6 hours ago • biz.chosun.com
Samsung Biologics wins accounting fraud trials as Financial Services Commission plans appeal8 hours ago • prnewswire.co.uk
WuXi Biologics Ireland Receives 2025 Operational Excellence in Life Sciences Award2025-06-16 • PR Newswire
Axio BioPharma Expands Advisory Board with Leaders in Biologics Development and Manufacturing2025-06-16 • PR Newswire
Innovent Announces Completion of First Participant Dosed in the Seventh Phase 3 Clinical Trial (GLORY-OSA) of Mazdutide in China2025-06-16 • PR Newswire
Samsung Biologics launches drug screening services, Samsung Organoids2025-06-13 • PR Newswire
Innovent to Present Multiple R&D Results of General Biomedicine Pipeline at the ADA's 85th Scientific Sessions2025-06-12 • PR Newswire
UCB Announces Major U.S. Investment to Expand Biologics Manufacturing Capacity2025-06-12 • genengnews.com
Nicoya Grows Biologics Characterization Capabilities with Applied Photophysics Acquisition2025-06-11 • biospace.com
Bonum Therapeutics to Participate in Panel on Conditionally Active Biologics at BIO 20252025-06-11 • PR Newswire
Specific Biologics Welcomes Paul J. Hastings as Chair of the Board of Directors2025-06-10 • PR Newswire
Akesis Biologics Launches MastGut: A Breakthrough Supplement That Uses DUSP10 Enzyme to Support Gut and Colorectal Health2025-06-09 • biz.chosun.com
Samsung Biologics targets CDMO growth at BioUSA with 13th solo booth2025-06-09 • PR Newswire
WuXi Biologics Kicks off Construction of Microbial Manufacturing Site for Commercial Production in Chengdu2025-06-06 • EIN Presswire
Global Agricultural Biologics Market Forecast: Key Growth Drivers, Trends, And Opportunities From 2025 To 20342025-06-05 • EIN Presswire
Biologics Contract Manufacturing Market to Hit $83.47B by 2033: Trends, Outlook & Leading Companies | DataM Intelligence2025-06-05 • prnewswire.co.uk
Preliminary Data from Two Clinical Trials with ADC Candidates were Presented Orally at the 2025 ASCO Annual Meeting2025-06-05 • PR Newswire
Innovent's IBI363 (PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) Receives Second NMPA Breakthrough Therapy Designation for Immuno-resistant Squamous Non-Small Cell Lung Cancer2025-06-05 • PR Newswire
Innovent and HUTCHMED Jointly Announce NDA Acceptance in China for Sintilimab Combination with Fruquintinib for the Treatment of Advanced Renal Cell Carcinoma2025-06-04 • financialexpress.com
With plans to acquire US-based genus Inc, Zydus Lifesciences set to enter the global biologics CDMO business2025-06-03 • businesswireindia.com
Agenus and Zydus Lifesciences Enter $141M Strategic Collaboration to Advance BOT/BAL, Expand Zydus’ Biologics Manufacturing in the US2025-06-04 • prnewswire.co.uk
Commit Biologics appoints leading industry experts to newly formed Scientific Advisory Board2025-06-04 • PR Newswire
2025 ASCO Oral Presentation: Innovent Biologics Announces Updated Data of IBI363 (First-in-class PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) from the Phase 1 PoC Clinical Study in Advanced Non-small Cell Lung Cancer2025-06-03 • businesswireindia.com
Zydus to Enter Global Biologics CDMO Business Plans to Acquire Agenus’ U.S. Manufacturing Facilities to Accelerate Development of Innovative Therapies2025-06-03 • PR Newswire
2025 ASCO Presentation: Innovent Biologics Announces Updated Data of IBI354 (Novel anti-HER2 ADC) From the Phase 1/2 Clinical Study in Advanced Ovarian Cancer, Breast Cancer and Other Solid Tumors2025-06-03 • PR Newswire
ASCO 2025 Oral Presentation: Innovent Biologics Announces Updated Data of IBI343 (Novel Anti-CLDN18.2 ADC) From the Phase 1 Clinical Study in Patients with Advanced Pancreatic Cancer2025-06-02 • PR Newswire
2025 ASCO Oral Presentation: Innovent Biologics Announces Updated Date of IBI363 (First-in-class PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) from Phase 1 Clinical Studies in Advanced Colorectal Cancer2025-06-01 • PR Newswire
ASCO 2025 Oral Presentation: Innovent Biologics Announces Updated Data of IBI363 (First-in-class PD-1/IL-2α -bias Bispecific Antibody Fusion Protein) from Phase 1 and 2 Clinical Studies on Immunotherapy-treated Advanced Malignant Melanoma2025-05-30 • EIN Presswire
Temperature Controlled Pharma Packaging Market to Double by 2035, Reaching USD 29,859.1 Million Amid Biologics Boom40 minutes ago • newswire.ca
FortisBC's Clean Growth Innovation Fund gets greenlight for next phase1 hour ago • motorfinanceonline.com
UK to install over 100,000 EV chargepoints1 hour ago • biomedwire.com
Intelligent Bio Solutions Inc. (NASDAQ: INBS) CEO Highlights Fingerprint Drug Testing on BioMedWire Podcast1 hour ago • theglobeandmail.com
GTA sees slowdown in home renovations as prices surge across Canada1 hour ago • recordnet.com
Stockton police Operation White Noise nets 21 arrests, including 3 homicide suspects1 hour ago • business-standard.com
Data Centres Open New Avenue For Real Estate Developers1 hour ago • railexpress.com.au
New standard developed for emerging technology1 hour ago • thetrucker.com
Paper Transport Expands Partnership With Green Bay Packers1 hour ago • news.iu.edu
Luddy School collaborates in award-winning Chip Kids web series1 hour ago • cointelegraph.com
Early Bitcoin adopter says BTC could have another 100X cycle1 hour ago • deadlinenews.co.uk
Management buyout for Scots civil engineering consultancy1 hour ago • business-standard.com
Premium Insurance Demand Spikes As Travel Disruptions Rise Globally9 minutes ago • EIN Presswire
Watertown Pediatric Dentistry’s Dr. Andrew Beuttenmuller Designated as Pediatric Dentistry Expert in HelloNation9 minutes ago • EIN Presswire
Unlocking Relief: How Innovation is Redefining the Atopic Dermatitis Treatment Landscape | Competitive Intelligence9 minutes ago • EIN Presswire
Atopic Dermatitis Market to Reach USD 40,234.20 Million by 2035, Report by IMARC Group1 hour ago • tradingview.com
Urals crude diffs inch up, prices firm above $60/bbl2 hours ago • marinelink.com
Russian Urals Oil Prices Rise Above Western Price Cap5 hours ago • kyivindependent.com
Russian military-industrial chemical plant halts operations after Ukrainian drone strike1 hour ago • business-standard.com
Data Centres Open New Avenue For Real Estate Developers1 hour ago • business-standard.com
Premium Insurance Demand Spikes As Travel Disruptions Rise Globally1 hour ago • tradebrains.in
Oil & Gas stock jumps 5% after reports on Delhi’s EV Policy Relaxation9 minutes ago • EIN Presswire
NEFT Vodka Brings Mini Eco-Friendly Barrels to The Bottle Club1 hour ago • motorfinanceonline.com
UK to install over 100,000 EV chargepoints1 hour ago • deadlinenews.co.uk
Management buyout for Scots civil engineering consultancyStay ahead with real-time headlines from top sources, categorized by sector and country.